Lapatinib and Dexamethasone Injection: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Lapatinib
Dexamethasone Injection
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
Decreased lapatinib exposure or plasma concentrations
Interaction Deep Dive
In healthy participants, concurrent administration of lapatinib with carbamazepine, a CYP3A4-inducer, led to significantly decreased lapatinib AUC (72%). Although studies have not been conducted with other CYP3A4-inducers, it is recommended that concurrent use of strong CYP3A4 inducers, such as dexamethasone, with lapatinib be avoided. However, if these agents must be used concurrently, then depending on tolerability, a gradual titration of lapatinib dose from 1250 mg/day up to 4500 mg/day should be considered. This adjustment is recommended based on pharmacokinetic data and would be expected to adjust lapatinib AUC to the therapeutic ranges achieved without CYP3A4 inducers. However, no clinical data is currently available with such adjustments. If dexamethasone is discontinued, the increased lapatinib dose should be reduced to the indicated dose1.
Why it happens (mechanism)
Induction of CYP3A4-mediated lapatinib metabolism
Common questions
Can I take Lapatinib and Dexamethasone Injection together?
Decreased lapatinib exposure or plasma concentrations Always confirm with your pharmacist or prescriber before making any change.
How serious is the Lapatinib and Dexamethasone Injection interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Lapatinib or Dexamethasone Injection need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: TYKERB(R) oral tablets, lapatinib oral tablets. GlaxoSmithKline, Research Triangle Park, NC, 2007. DailyMed
Keep reading about Lapatinib
Keep reading about Dexamethasone Injection
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist